WELCOME TO A.C.T.I.O.N IN MYELOMA – ON-DEMAND COURSE
Learning Objectives
Share real-life insights on factors that contribute to treatment decision-making when initiating new myeloma therapies
Apply practical considerations related to dosing and administration of novel anti-BCMA therapies, including antibody-drug conjugates (ADCs), to support evidence-based,
patient-centred treatment management
Demonstrate how to streamline collaboration with other healthcare professionals, with a focus on adverse event management
You can take the course in your preferred language using the language toggle at the top of the page!
Featuring Expert Speakers:
Tina Crosbie, BPharm, ACPR, RPh
Clinical Pharmacist, Hematology
The Ottawa Hospital
Ottawa, ON
Michelle Forman, RN, CON(c)
Oncology Nurse
Burnaby Cancer Centre
Burnaby, BC
You can take the course in your preferred language using the language toggle at the top of the page!
Featuring Expert Speakers:
Marie-Pier Lecours-Cyr, BSc Nursing
Research Coordinator,
Hematology / Oncology / Multiple Myeloma
CIUSSS de l'Est-de-l'Île-de-Montréal
Hôpital Maisonneuve-Rosemont
Montréal, QC
Dominic Duquette, BPharm, MS
Clinical Pharmacist,
Clinical Research Pharmacist
Centre de recherche du CHU
CEC – Québec-Université Laval
Québec City, QC